Table of Contents    
ARTICLE
Year : 2011  |  Volume : 2  |  Issue : 3  |  Page : 124  

Effects of zinc sulphate supplementation on inflammatory marker and lipid levels in type-2 diabetic nephropathy patients 1-4


1 Department of Community Medicine, CSM Medical University UP, Lucknow, India
2 Department of Medicine, CSM Medical University UP, Lucknow, India
3 Department of Pathology, CSM Medical University UP, Lucknow, India

Date of Web Publication26-May-2012

Correspondence Address:
W Ali
Department of Pathology, CSM Medical University UP, Lucknow
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

How to cite this article:
Khan M I, Usman K, Ali W, Idris M Z. Effects of zinc sulphate supplementation on inflammatory marker and lipid levels in type-2 diabetic nephropathy patients 1-4. J Nat Sc Biol Med 2011;2, Suppl S1:124

How to cite this URL:
Khan M I, Usman K, Ali W, Idris M Z. Effects of zinc sulphate supplementation on inflammatory marker and lipid levels in type-2 diabetic nephropathy patients 1-4. J Nat Sc Biol Med [serial online] 2011 [cited 2020 Feb 24];2, Suppl S1:124. Available from: http://www.jnsbm.org/text.asp?2011/2/3/124/96242

The microvascular complications of diabetes may be mediated, at least in part, through oxidative stress and Zn plays a key role in the cellular antioxidative defense. If there is insufficient Zn, oxidative stress may damage the cell irreversibly, producing inflammation.This study to evaluate the effects of zinc sulfate in comparison with placebo on markers of glycemic control, inflammation and lipid levels in type-2 diabetes with microalbuminuria patients. Type-2 diabetes with microalbuminuria patients were divided into two groups. One group (n=27) received a placebo, second group (n=27) received 50 mg zinc as zinc sulphate. Both groups received oral hypoglycaemic agent with ACE inhibitors. Biochemical and 24 urine examination were carried out at the start of the treatment and after 12 weeks of the regimens. This double blind, randomized, placebo-controlled trial was conducted among north Indian patients. In addition to anthropometric measures and blood pressure, fasting plasma glucose, Post-Prandial glucose, lipid profile, high-sensitivity C-reactive protein (hs-CRP) and 24-hrs urine microalbumin levels were determined.There were no significant differences in biochemical status amongst groups at baseline. After 12 weeks, the number of patients was almost equal in all the groups. Irrespective of the order of receiving zinc and placebo, in both groups, significant decrease was documented for total and LDL-cholesterol after receiving zinc without significant change after receiving placebo. In groups, hs-CRP markers of inflammation decreased significantly after receiving zinc. In both groups, the mean body mass index (BMI) remained high, after receiving zinc, decreased significantly. Thus it seems likely that zinc supplementation to diabetic nephropathy patients provide effective antioxidative/anti-inflammatory protection.




 

Top
  
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article

 Article Access Statistics
    Viewed833    
    Printed77    
    Emailed0    
    PDF Downloaded171    
    Comments [Add]    

Recommend this journal